Intramyocardium application of mesenchymal stem cells combined with erythropoetin improves left ventricle function in a rat myocardial infarction model

Thoracic and Cardiovascular Surgeon(2007)

Cited 0|Views5
No score
Abstract
Objective: Erythropoetin (Epo) has angiogenetic, cytoprotective and anti-inflammatory properties. In this study we investigated the beneficial effect of a local Epoetin-a administration in combination with a mesenchymal stem cell therapy in a rat myocardial infarction model.
More
Translated text
Key words
mesenchymal stem cell,myocardial infarct
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined